Invention Application
US20110034694A1 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
失效
具有BETA2 ADRENERGIC受体激动剂和MUSCARINIC受体拮抗剂活性的化合物
- Patent Title: COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
- Patent Title (中): 具有BETA2 ADRENERGIC受体激动剂和MUSCARINIC受体拮抗剂活性的化合物
-
Application No.: US12903365Application Date: 2010-10-13
-
Publication No.: US20110034694A1Publication Date: 2011-02-10
- Inventor: Mathai MAMMEN , Sarah DUNHAM
- Applicant: Mathai MAMMEN , Sarah DUNHAM
- Applicant Address: US CA South San Francisco
- Assignee: THERAVANCE, INC.
- Current Assignee: THERAVANCE, INC.
- Current Assignee Address: US CA South San Francisco
- Main IPC: C07D417/12
- IPC: C07D417/12
Abstract:
The invention is directed to compounds of formula I: wherein R1, R2, R3, R4, R5, R6, R7a, R7b, W, G1, G2, a, b, c, d and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
Public/Granted literature
- US08247564B2 Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity Public/Granted day:2012-08-21
Information query
